Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur J Obstet Gynecol Reprod Biol ; 190: 71-5, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25996518

RESUMO

OBJECTIVE: To evaluate whether xenografts derived from hysterectomized patients would implant successfully and lead to uterine leiomyoma in Wistar rats. STUDY DESIGN: This experimental study examined six female Wistar rats implanted with uterine leiomyoma obtained from patients who underwent hysterectomies at the gynecological surgery service of the HUUFMA. The rats were divided into two groups. Group I consisted of three rats in which the uterine leiomyoma had been implanted in the parietal peritoneum, and group II consisted of three rats in which the uterine leiomyoma was implanted in the subcutaneous tissue. The immunosuppressant mycophenolate mofetil (MMF) was administered orally by gavage (at a dose of 40 mg/kg of body weight) to prevent transplant rejection starting 15 days before the transplant and continuing throughout the entire experiment. After four weeks, necrosis and neovascularization were evaluated histologically in both groups and were classified as either absent or present. Lymphocytic inflammatory infiltration was also examined and classified as mild, moderate or intense (by hematoxylin and eosin staining), and fibrosis was classified as grade I-III (by Masson's trichrome staining). RESULTS: Necrosis was absent from all three rats in group I and was observed in only one rat from group II. Neovascularization was present in two rats from group I and in only one rat from group II. The lymphocytic inflammatory infiltrate was mild in two rats and moderate in one rat from group I, and it was moderate in two rats and intense in one rat from group II. Two rats from group 1 exhibited grade III fibrosis, and one rat presented grade I fibrosis. In group II, two rats presented grade I fibrosis and one rat had grade II fibrosis. When necrosis and neovascularization were evaluated as variables, group I demonstrated greater evidence of successful implantation when compared to group II, indicating that the peritoneal implantation technique produces better results than the subcutaneous approach (p=0.039). CONCLUSION: This study demonstrates that the xenotransplantation of uterine leiomyoma into the parietal peritoneum is more effective than the xenotransplantation of uterine leiomyoma into the subcutaneous tissue, and it describes a promising new model for the study of leiomyoma in vivo.


Assuntos
Modelos Animais de Doenças , Leiomioma/patologia , Transplante de Neoplasias/métodos , Peritônio/patologia , Tela Subcutânea/patologia , Neoplasias Uterinas/patologia , Animais , Feminino , Fibrose , Rejeição de Enxerto/prevenção & controle , Humanos , Imunossupressores , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/análogos & derivados , Necrose/patologia , Neovascularização Patológica/patologia , Projetos Piloto , Ratos , Ratos Wistar , Transplante Heterólogo
2.
Acta Cir Bras ; 26 Suppl 2: 15-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22030809

RESUMO

PURPOSE: Evaluate the histological changes in parenchyma's epithelial layer of the uterus and ovarian of rats with induced endometriosis, treated with Uncaria tomentosa extract. METHODS: 29 rats with experimental endometriosis, were selected and divided in three groups: The uncaria group received 32 mg/ml of Uncaria tomentosa extract, 1 ml administered daily and the placebo group received 1 ml of saline 0.9% per day, during for 14 days (both groups); the leuprolide group received leuprolide acetate 1mg/kg body weight applied single subcutaneous dose. In the 15th day of treatment the uterine horn and ovaries were removed for histopathological analysis. RESULTS: The uncaria group presented nine samples (90%) with immature ovarian follicles, whereas the placebo group did not present any case and in the leuprolide group there were eight rats (88%) with the same change. The placebo group showed mature corpus luteum in all animals, occurring less frequent in uncaria (10%) and leuprolide (22%) groups. The uterine epithelium showed weak proliferative in nine (90%) samples of the uncaria group, in two (20%) animals in the placebo group and seven (77.8%) rats in the leuprolide group. CONCLUSIONS: The findings suggest that Uncaria tomentosa has contraceptive effect.


Assuntos
Unha-de-Gato/química , Anticoncepcionais/uso terapêutico , Endometriose/tratamento farmacológico , Endometriose/patologia , Fitoterapia , Extratos Vegetais/uso terapêutico , Animais , Modelos Animais de Doenças , Feminino , Distribuição Aleatória , Ratos , Ratos Wistar , Resultado do Tratamento , Útero/efeitos dos fármacos , Útero/patologia
3.
Acta cir. bras ; 26(supl.2): 15-19, 2011. ilus, tab
Artigo em Inglês | LILACS | ID: lil-602638

RESUMO

PURPOSE: Evaluate the histological changes in parenchyma´s epithelial layer of the uterus and ovarian of rats with induced endometriosis, treated with Uncaria tomentosa extract. METHODS: 29 rats with experimental endometriosis, were selected and divided in three groups: The uncaria group received 32mg/ml of Uncaria tomentosa extract, 1ml administered daily and the placebo group received 1ml of saline 0.9 percent per day, during for 14 days (both groups); the leuprolide group received leuprolide acetate 1mg/kg body weight applied single subcutaneous dose. In the 15th day of treatment the uterine horn and ovaries were removed for histopathological analysis. RESULTS: The uncaria group presented nine samples (90 percent) with immature ovarian follicles, whereas the placebo group did not present any case and in the leuprolide group there were eight rats (88 percent) with the same change. The placebo group showed mature corpus luteum in all animals, occurring less frequent in uncaria (10 percent) and leuprolide (22 percent) groups. The uterine epithelium showed weak proliferative in nine (90 percent) samples of the uncaria group, in two (20 percent) animals in the placebo group and seven (77.8 percent) rats in the leuprolide group. CONCLUSIONS: The findings suggest that Uncaria tomentosa has contraceptive effect.


OBJETIVO: Avaliação histológica do útero e parênquima ovariano de ratas com endometriose induzida tratadas com extrato de Uncaria tomentosa. MÉTODOS: Foram selecionadas 29 ratas com endometriose experimental e formados três grupos: O grupo uncaria recebeu extrato de Uncaria tomentosa com 32mg/ml, administrado 1ml ao dia e o grupo placebo recebeu 1ml de solução salina a 0,9 por cento, ambos por 14 dias; o grupo leuprolida recebeu acetato de leuprolida 1mg/kg de peso corporal aplicado via subcutânea dose única. No 15° dia de tratamento realizou-se retirada de corno uterino e ovários para análise histopatológica. RESULTADOS: O grupo uncaria apresentou nove amostras (90 por cento) com maturação incompleta dos folículos ovarianos, já o grupo placebo não apresentou nenhum caso e no grupo leuprolida houve oito ratas (88 por cento) com a mesma alteração. O grupo placebo apresentou corpo lúteo maduro em todos os animais, acontecendo de forma menos freqüente nos grupos uncaria (10 por cento) e leuprolida (22 por cento). O epitélio uterino se mostrou fracamente proliferativo em nove (90 por cento) das amostras do grupo unacaria, em dois (20 por cento) casos do grupo placebo e sete (77.8 por cento) casos no grupo leuprolida. CONCLUSÃO: Os achados sugerem que a Uncaria tomentosa tem efeito anticoncepcional.


Assuntos
Animais , Feminino , Ratos , Unha-de-Gato/química , Anticoncepcionais/uso terapêutico , Endometriose/tratamento farmacológico , Endometriose/patologia , Fitoterapia , Extratos Vegetais/uso terapêutico , Modelos Animais de Doenças , Distribuição Aleatória , Ratos Wistar , Resultado do Tratamento , Útero/efeitos dos fármacos , Útero/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA